RRML - The grade of neoangiogenesis and the bone marrow blast count predict leukemic transformation-free survival in myelodysplastic syndromes
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Română English


Journal Metrics

Impact Factor 0.493
Five Year Impact Factor 0.531
SNIP 0.373
JCI 0.17


Advanced search


Top 10 downloaded articles
- December 2022 -
 
Downregulation of hsa-miR-4328... 5
Normality assessment, few para... 4
Setting up an own laboratory p... 3
The relationship between matri... 2
New Para-Clinical Investigatio... 2
New high-throughput liquid chr... 2
General Principles of Haematop... 2
Genetic risk factors for throm... 2
The importance of the new prog... 2
Detection of chromosomal imbal... 2

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 24(2)/2016 DOI:10.1515/rrlm-2016-0020
XML
TXT

Letter to the editor

The grade of neoangiogenesis and the bone marrow blast count predict leukemic transformation-free survival in myelodysplastic syndromes

Emőke Horváth, Csilla Finna, Smaranda Demian, Előd-Ernő Nagy

Correspondence should be addressed to: Előd-Ernő Nagy

Abstract:

This is a Letter to Editor, therefore no abstract is included.

Received: 17.1.2016
Accepted: 19.4.2016
Published: 31.5.2016

 
  PDF Download full text PDF
(280 KB)
     
 
How to cite
Horváth E, Finna C, Demian S, Nagy EE. The grade of neoangiogenesis and the bone marrow blast count predict leukemic transformation-free survival in myelodysplastic syndromes. Rev Romana Med Lab. 2016;24(2):228-31. DOI:10.1515/rrlm-2016-0020